Identification of substituted cathinones: 3,4-Methylenedioxy derivatives by high performance liquid chromatography-quadrupole time of flight mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 81-82, Issue , 2013, Pages 13-19

  Fornal, Emilia ^a  

^a JOHN PAUL II CATHOLIC UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Designer drugs; LC MS MS; Legal highs; Liquid chromatography high resolution tandem mass spectrometry; Psychoactive substances; Substituted cathinones

Indexed keywords

3,4 METHYLENEDIOXY DERIVATIVE; BUTYLONE; CATHINONE; METHYLONE; PENTYLONE; PHENYLOXAZOLE; UNCLASSIFIED DRUG;

ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

ALKALOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; MASS SPECTROMETRY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84876719447     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.03.016     Document Type: Article

References (35)

1. Coppola M., Mondola R. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as bath salts "or plant food". Toxicol. Lett. 2012, 211:144-149.
2. Kelly J.P. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test. Anal. 2011, 3:439-453.
3. Dargan P.I., Sedefov R., Gallegos A., Wood D.M. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test. Anal. 2011, 3:454-463.
4. Karila L., Reynaud M. GHB and synthetic cathinones: clinical effects and potential consequences. Drug Test. Anal. 2011, 3:552-559.
5. Prosser J.M., Nelson L.S. The toxicology of bath salts: a review of synthetic cathinones. J. Med. Toxicol. 2012, 8:33-42.
6. Wood D.M., Dargan P.I. Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity. Prog. Neur.-Psychopharmacol. 2012, 39:227-233.
7. Derungs A., Schietzel S., Meyer M.R., Maurer H.H., Krahenbuhl S., Liechti M.E. Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone). Clin. Toxicol. 2011, 49:691-693.
8. Dargan P.I., Albert S., Wood D.M. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 2010, 103:875-879.
9. Fass J.A., Fass A.D., Garcia A.S. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann. Pharmacother. 2012, 46:436-441.
10. Kikura-Hanajiri R., Uchiyama N., Goda Y. Survey of current trends in the abuse of psychotropic substances and plants in Japan. Legal Med. 2011, 13:109-115.
11. Spiller H.A., Ryan M.L., Weston R.G., Jansen J. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin. Toxicol. 2011, 49:499-505.
12. Van Hout M.C., Brennan R. Plant food for thought: a qualitative study of mephedrone use in Ireland. Drugs: Educ. Prev. Policy 2011, 18:371-381.
13. Wood D.M., Greene S.L., Dargan P.I. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg. Med. J. 2011, 28:280-282.
14. Vardakou I., Pistos C., Spiliopoulou C. Drugs for youth via Internet and the example of mephedrone. Toxicol. Lett. 2011, 201:191-195.
15. Brandt S.D., Sumnall H.R., Measham F., Cole J. Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test. Anal. 2010, 2:377-382.
16. Brandt S.D., Freeman S., Sumnall H.R., Measham F., Cole J. Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. Drug Test. Anal. 2011, 3:569-575.
17. Brandt S.D., Daley P.F., Cozzi N.V. Analytical characterization of three trifluoromethyl-substituted methcathinone isomers. Drug Test. Anal. 2012, 4:525-529.
18. Westphal F., Junge T., Girreser U., Greibl W., Doering C. Mass, NMR and IR spectroscopic characterization of pentedrone and pentylone and identification of their isocathinone by-products. Forensic Sci. Int. 2012, 217:157-167.
19. Westphal F., Junge T., Klein B., Fritschi G., Girreser U. Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: a new designer drug with alpha-pyrrolidinophenone structure. Forensic Sci. Int. 2011, 209:126-132.
20. Santali E.Y., Cadogan A.K., Daeid N.N., Savage K.A., Sutcliffe O.B. Synthesis, full chemical characterisation and development of validated methods for the quantification of (±)-4'-methylmethcathinone (mephedrone): a new "legal high". J. Pharm. Biomed. Anal. 2011, 56:246-255.
21. McDermott S.D., Power J.D., Kavanagh P., O'Brien J. The analysis of substituted cathinones. Part 2: an investigation into the phenylacetone based isomers of 4-methylmethcathinone and N-ethylcathinone. Forensic Sci. Int. 2011, 212:13-21.
22. Kavanagh P., O'Brien J., Fox J., O'Donnell C., Christie R., Power J.D., McDermott S.D. The analysis of substituted cathinones. Part 3. Synthesis and characterisation of 2,3-methylenedioxy substituted cathinones. Forensic Sci. Int. 2012, 216:19-28.
23. Power J.D., McGlynn P., Clarke K., McDermott S.D., Kavanagh P., O'Brien J. The analysis of substituted cathinones. Part 1: chemical analysis of 2-, 3-and 4-methylmethcathinone. Forensic Sci. Int. 2011, 212:6-12.
24. Locos O., Reynolds D. The characterization of 3,4-dimethylmethcathinone (3,4-DMMC). J. Forensic Sci. 2012, 57:1303-1306.
25. Camilleri A., Johnston M.R., Brennan M., Davis S., Caldicott D.G.E. Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci. Int. 2010, 197:59-66.
26. Jankovics P., Varadi A., Tolgyesi L., Lohner S., Nemeth-Palotas J., Koszegi-Szalai H. Identification and characterization of the new designer drug 4'-methylethcathinone (4-MEC) and elaboration of a novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening method for seven different methcathinone analogs. Forensic Sci. Int. 2011, 210:213-220.
27. Gibbons S., Zloh M. An analysis of the 'legal high' mephedrone. Bioorg. Med. Chem. Lett. 2010, 20:4135-4139.
28. Khreit O.I.G., Irving C., Schmidt E., Parkinson J.A., Daeid N.N., Sutcliffe O.B. Synthesis, full chemical characterisation and development of validated methods for the quantification of the components found in the evolved "legal high" NRG-2. J. Pharm. Biomed. Anal. 2012, 61:122-135.
29. Wohlfarth A., Weinmann W., Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal. Bioanal. Chem. 2010, 396:2403-2414.
30. Sorensen L.K. Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B 2011, 879:727-736.
31. Meyer M.R., Vollmar C., Schwaninger A.E., Wolf E.U., Maurer H.H. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J. Mass Spectrom. 2012, 47:253-262.
32. Diaz R., Ibanez M., Sancho J.V., Hernandez F. Target and non-target screening strategies for organic contaminants, residues and illicit substances in food, environmental and human biological samples by UHPLC-QTOF-MS. Anal. Method 2012, 4:196-209.
33. Zuba D. Identification of cathinones and other active components of 'legal highs' by mass spectrometric methods. Trend. Anal. Chem. 2012, 32:15-30.
34. Reitzel L.A., Dalsgaard P.W., Muller I.B., Cornett C. Identification of then new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish Internet company. Drug Test. Anal. 2012, 4:342-354.
35. Fornal E., Stachniuk A. LC-Q/TOF mass spectrometry data driven identification and spectroscopic characterisation of a new 3,4-methylenedioxy-N-benzyl cathinone (BMDP). J. Pharm. Biomed. Anal. 2013, 72:139-144.